Stock Events

Stock Events

UroGen Pharma (URGN) Q2 2025 Earnings

12MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.92

-0.8

-0.67

-0.55

Details

Expected EPS

-0.799319

Actual EPS

-0.92

Surprise EPS

-0.12

Surprise Percent

+15.1%

Description

UroGen Pharma (URGN) has reported earnings of -0.92 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.